{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "4983833", "DateCompleted": {"Year": "1970", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["ger"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0044-4197", "JournalIssue": {"Volume": "91", "Issue": "37", "PubDate": {"Year": "1969", "Month": "Sep", "Day": "13"}}, "Title": "Zentralblatt fur Gynakologie", "ISOAbbreviation": "Zentralbl Gynakol"}, "ArticleTitle": "[Cytostatic treatment of genital carcinoma].", "Pagination": {"StartPage": "1193", "EndPage": "1203", "MedlinePgn": "1193-203"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Limburg", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article"], "VernacularTitle": "Die zytostatische Behandlung der Genitalkarzinome."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Zentralbl Gynakol", "NlmUniqueID": "21820100R", "ISSNLinking": "0044-4197"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkylating Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antibiotics, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimetabolites"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "5V9KLZ54CY", "NameOfSubstance": "Vinblastine"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "905Z5W3GKH", "NameOfSubstance": "Thiotepa"}, {"RegistryNumber": "F3D5D9P25I", "NameOfSubstance": "Triaziquone"}, {"RegistryNumber": "YL5FZ2Y5U1", "NameOfSubstance": "Methotrexate"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Alkylating Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antibiotics, Antineoplastic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antimetabolites"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Carcinoma, Papillary"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug therapy", "mortality"], "DescriptorName": "Genital Neoplasms, Female"}, {"QualifierName": [], "DescriptorName": "Germany, West"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Methotrexate"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Podophyllum"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Thiotepa"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Triaziquone"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Uterine Cervical Neoplasms"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Uterine Neoplasms"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vinblastine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1969", "Month": "9", "Day": "13"}, {"Year": "1969", "Month": "9", "Day": "13", "Hour": "0", "Minute": "1"}, {"Year": "1969", "Month": "9", "Day": "13", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4983833"]}}], "PubmedBookArticle": []}